Given the relatively high level of gross Medicare Part D spending as of 2022 for the two semaglutide products combined, Ozempic and Rybelsus, its possible that Medicare could select this product for drug price negotiation as early as 2025, which would be just over seven years past its earliest FDA approval in late 2017
By activating Nrf2, the expression of downstream signaling molecules, such as HO-1, can be induced to exert an anti-oxidative stress response (40)
As a comparison, superimposing either GIP or GCG with GLP-1 analogs suggest that they have potential steric clashes with ECL1 of GLP-1R via H18 P of GIP and R18 P of GCG
In the published Phase 2 obesity trial (Jastreboff et al., NEJM 2023), doses of up to 12 mg once weekly were studied
The antioxidant balance is delicate